News

Filter

Current filters:

RebifBayer

1 to 9 of 27 results

Promising Ph II data for Genzyme/Bayer's alemtuzumab

27-10-2008

Findings from a mid-stage study suggest that leukemia drug Campath (alemtuzumab) can have a large and…

AlemtuzumabAspirinAvonexBayerBayerCampathGenzymeInterferon beta-1aMerck KGaARebif

New Rebif formulation launched in UK

10-03-2008

Switzerland-based Merck Serono, a division of Germany's Merck KGaA, says that a new formulation of its…

Amino AcidsAspirinAvonexBayerBayerBetaseronInjectionInterferon beta-1aInterferon beta-1bMerck KGaAPhysostigmine SalicylateRebif

Betaseron linked to fewer injection site reactions

12-11-2007

Bayer HealthCare Pharmaceuticals, part of Germany's Bayer, says that multiple sclerosis patients treated…

Amino AcidsAspirinAvonexBayerBayerBetaseronInjectionInterferon beta-1aInterferon beta-1bMerck KGaAPhysostigmine SalicylateRebif

Alemtuzumab cuts relapse risk in RRMS

22-10-2007

US biotechnology major Genzyme says that three-year data comparing alemtuzumab with Merck Serono's Rebif…

AlemtuzumabAspirinAvonexBayerBayerCampathFludaraFludarabineGenzymeInterferon beta-1aMerck KGaARebif

1 to 9 of 27 results

COMPANY SPOTLIGHT

Menarini

Back to top